The battle for GBST Holdings has just heated up with private equity-backed global fintech FNZ making a $3.50 a share indicative offer just hours after SS&C Technologies made their $3.25 a share bid for the company.

FNZ is privately held and backed by institutional shareholders. Its biggest investors is CDPQ - a $200 billion-odd Canadian pension fund, which spearheaded the company's buyout late last year.

Street Talk has the full story here.

The RBA is likely to cut interest rates when it meets on Tuesday although there is still some uncertainty.

While futures markets are betting the cash rate will be cut, they are less optimistic than they were in the middle of June when they were implying a 84 per cent probability.

18 of the 26 economists surveyed by Bloomberg believes the board will make the decision to cut to 1 per cent.

All four of the major banks are forecasting a 0.25 percentage point cut but HSBC, Morgan Stanley, Citi and UBS believe the Reserve Bank will remain on hold.

Macquarie retained its 'underperform' rating on ResMed but increased its price target on the medical equipment company, saying while it saw good opportunities in the medium-longer term, its multiple was elevated.

"Over the medium-longer term, we see scope for increased uptake of PAP (positive airway pressure) therapy in the US via increased awareness and diagnosis of sleep related disorders," said analyst David Bailey.

"However, we see the current share price as ascribing limited medium-term risk in relation to reimbursement changes and/or longer-term impacts from competing technologies."

Macquarie increased its price target on ResMed to $15.00 from $14.25.

Australia is about to reach its last percentage point of interest-rate ammunition, dragging the country's economy and markets deeper into the low-yield world that's already engulfed many of its developed-world peers.

Yields on the nation's 10-year government bonds hit an all-time low 1.26 per cent last week, more than a percentage point below where they started the year.

The slide means every Australian bond -- out to the longest maturity of 2047 -- is yielding less than the bottom of the central bank's 2-3 per cent inflation target.

Read the full story here.

The financial regulator says IOOF's former chief executive Chris Kelaher and ex-chairman George Venardos put the company's interests before those of superannuation fund members as it kicked off its legal case against the troubled wealth group.

In a rare enforcement case for the Australian Prudential Regulation Authority (APRA), it is seeking to have Mr Kelaher, Mr Venardos and several IOOF executives disqualified from working in the superannuation sector.

The case opened at the Federal Court on Monday before Justice Jayne Jagot, with Mr Kelaher sitting in the front row of the public gallery watching proceedings.

Clancy Yeates has the full story here.

Australian shares are trading higher despite dipping slightly through the early afternoon.

The S&P/ASX 200 Index is up 31.9 points, or 0.5 per cent, to 6650.7.

BHP Group is up 1.1 per cent, CSL has risen 0.7 per cent and Macquarie is up 1.8 per cent.

Link Administration has advanced 5.9 per cent, Galaxy Resources is trading 5.3 per cent higher an Unibail-Rodamco-Westfield is up 4.7 per cent.

For investors in Afterpay, the most worrying thing in Visa's announcement that it's entering the buy now, pay later space isn't necessarily the specific threat of competition from one of the world's biggest financial services companies.

Rather, the most concerning aspect of the announcement was a number: $US1.2 trillion ($1.7 trillion). That's Visa's view of the buy now, pay later sector, which it prefers to describe as the "instalments" market.

An optimist might say Visa's desire to enter this market, one supported by an avalanche of statistics about sectoral growth, is validation of Afterpay's belief that consumers are shifting away from products like credit cards and towards new payment models that are more about budgeting than borrowing.

But a pessimist would say that this $1.7 trillion honey pot will create several waves of competition for Afterpay at a time it's been made vulnerable through ambitious growth plans, the poorly timed decision of its founders to sell stock, and corporate governance weaker than it should be for $5.9 billion company.

Chanticleer has the full story here.

Local financial services, broking and wealth management software company GBST has another potential suitor.

NASDAQ-listed tech company SS&C Technologies has lobbed a $3.25 per share non-binding bid at the company, 25¢ higher than competitor Bravura's $3 per share non-binding bid made last week.

GBST granted SS&C Technologies access to its data room and indicated it intended to unanimously recommend the proposal to shareholders should it materialise into a formal bid.

Yolanda Redrup has the full story here.

Syrah Resources, Nufarm, Inghams, JB Hi-Fi, Bellamy's Australian, BWX and Bingo Industries are among the most shorted stocks on the Australian Securities Exchange.

Other companies have have better fortune in the last few months. Myer is no longer in the top 10 most shorted stocks and has fallen to number 28 on the list as new chief executive John King battles to lift returns and restore some stability.

Simon Evans has the full story here.

Suncorp Group has become the latest company to be hit with a post-Hayne royal commission class action.

The proceedings, filed to the NSW Supreme Court, concerns superannuation commission paid to financial advisors which Suncorp has said it will defend.

Read the full story here.